The newest devices, procedures and research projects are paving new paths for patients with heart rhythm disorders like atrial fibrillation and ventricular arrhythmia.
Connect with us:
Cedars-Sinai is a leader in providing high-quality healthcare encompassing primary care, specialized medicine and research. Since 1902, Cedars-Sinai has evolved to meet the needs of one of the most diverse regions in the nation, setting standards in quality and innovative patient care, research, teaching and community service. Today, Cedars- Sinai is known for its national leadership in transforming healthcare for the benefit of patients. Cedars-Sinai impacts the future of healthcare by developing new approaches to treatment and educating tomorrow’s health professionals. Additionally, Cedars-Sinai demonstrates a commitment to the community through programs that improve the health of its most vulnerable residents.
Learn more in this
related article. Cardiac electrophysiology is a sub specialty of cardiology that really deals with patients with heart rhythm related disorders. So either in many cases prevention of certain disorders or active treatment of patients that are born with a cardiac rhythm problem or acquire a cardiac rhythm problem over the course of their lives. The most common condition we treat is amongst an older population, which is atrial fibrillation, the most common cardiac rhythm problem worldwide, but we also deal with patients that are born with certain congenital arrhythmias or rhythm problems. The majority of of procedures that we do in the heart rhythm world or this space of electrophysiology is really what's called catheter ablation. So, using catheters in a minimally invasive way, going generally from veins in the groin, up into the heart to map out and find areas that are leading to heart rhythm disorders and essentially, a blading or getting rid of that abnormal tissue that causes the problem. One of the dramatic developments within the treatment of slow heart rhythm disorders has been the development of pacemakers that are completely lied. Lys, miniaturizing all of the components of a pacemaker into a very small device which is actually implanted within the heart tissue embedded within the heart tissue and left there. And this device is about the size of a quarter, even narrower than the size of a quarter, and is meant to be placed within the right lower chamber of the heart, providing all of the pacing technologies that a standard pacemaker has without all the long term complications, the number one kind of morbidity or problem with atrial fibrillation may not be the rhythm itself per se, but the risk that it puts patients out for stroke. So about 20 to 25% of all the strokes in the United States are related directly to clot formation during or after these rhythm disorders. So in some patients that can't tolerate taking blood thinning medicines for life, we have these devices that can occlude or close the left atrial appendage And prevent them from having clot formation or future strokes and not having to take blood thinners, which have many side effects. And in some patients, so those are just a number of examples of newer therapies that have emerged really within the last 5 to 10 years, uh and the future going forward is very bright.